Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
GSK backs Avandia again amid renewed pressure for withdrawal
Pharma Times, UK
Tue, 06/29/10 - 09:08 am
GSK
Avandia
diabetes
Why Avandia Will Change The Drug Industry
Forbes
Tue, 06/29/10 - 09:07 am
Avandia
GSK
diabetes
Avandia, Heart Attacks & An Upcoming FDA Meeting
Pharmalot
Mon, 06/28/10 - 01:43 pm
Avandia
heart attacks
GSK
diabetes
FDA
Actos
Takeda
5 Reasons Why Amarin Is My Top Buy
Seeking Alpha
Sun, 06/27/10 - 11:23 am
Amarin
Epadel
GSK
Lovaza
omega-3 fatty acid
AMR101
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Seeking Alpha
Sun, 06/27/10 - 11:04 am
Anthera
A-002
acute coronary syndrome
GSK
darapladib
Wonder Drugs
Barron's
Sat, 06/26/10 - 11:15 am
Pfizer
Merck
AstraZeneca
GSK
BMS
Novartis
Sanofi
Eli Lilly
Merck Breathes Life Into an Acquired Pipeline
Motley Fool
Sat, 06/26/10 - 09:22 am
Merck
Dulera
asthma
Novartis
Fordadil
Symbicort
Advair
AstraZeneca
GSK
COPD
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
Sat, 06/26/10 - 09:17 am
obesity
Orexigen
Qnexa
Vivus
Abbott Laboratories
GSK
Meridia
Alli
Drugmakers Finally Recognize the Next Big Opportunity
Motley Fool
Thu, 06/24/10 - 08:38 am
BioSante
Merck
GSK
Abbott Laboratories
Neurocrine
Teva Pharmaceuticals
women
Biotech Stocks Losing Strength
Minyanville
Wed, 06/23/10 - 10:56 am
biotech
Amgen
Gilead Sciences
Biogen Idec
Merck
Eli Lilly
Pfizer
GSK
Glaxo Settles Nearly 200 Paxil Birth Defect Lawsuits
Pharmalot
Wed, 06/23/10 - 09:08 am
Paxil
antidepressants
settlements
lawsuits
birth defects
GSK
[video] Glaxo CEO on Global Health Challenges
CNBC
Wed, 06/23/10 - 09:04 am
GSK
Andrew Witty
Pharma CEOs
GSK, Merck tops at delivering meds to the poor
Fierce Pharma
Mon, 06/21/10 - 12:12 pm
GSK
Merck
Good News for Immunomedics Pipeline
Yahoo/Zacks.com
Mon, 06/21/10 - 12:05 pm
Immunomedics
Human Genome Sciences
GSK
epratuzumab
UCB Pharmaceuticals
lupus
GlaxoSmithKline lupus drug candidate does well in phase III trials
Bizjournals.com
Thu, 06/17/10 - 06:50 pm
GSK
lupus
Benlysta
Human Genome Sciences
Should Gilead Sciences Declare a Dividend?
Seeking Alpha
Thu, 06/17/10 - 06:48 pm
Gilead Sciences
dividends
Bristol-Myers Squibb
GSK
GlaxoSmithKline, Amfar Form Pact To Optimize HIV Treatment In Asia
WSJ
Thu, 06/17/10 - 11:22 am
GSK
Amfar
HIV
Asia
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Pharmabiz
Thu, 06/17/10 - 09:50 am
GSK
Votrient
renal cell carcinoma
Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at EULAR of BLISS-76 Phase 3 Study Results for BENLYSTA® in Systemic Lupus Erythematosus
Yahoo/BusinessWire
Thu, 06/17/10 - 08:50 am
Human Genome Sciences
GSK
Benlysta
lupus
Leaner Isn't Meaner for 9 Big Pharma Firms That Tried to Cut Their Way to Greatness
BNET Pharma
Wed, 06/16/10 - 10:49 am
Pfizer
Merck
Wyeth
Schering Plough
GSK
Eli Lilly
Abbott Laboratories
Gilead Sciences
CV Therapeutics
consolidation
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »